Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Sociodemographic factors may play a role in whether people receive immunotherapy.
Cholesterol-lowering medications were associated with at least a 40% reduction in mortality.
These cancers include those that are rare among adults under 40, such as breast, colon, pancreas, kidney, prostate and ovarian cancer.
A recent study found that blood testing could help with early detection of numerous malignancies.
An early study in mice had suggested the on-again, off-again dosing strategy would help shrink tumors.
A study of melanoma patients found that treatment every six weeks is comparable to every three weeks.
Cancer type, stage and treatment appear to affect the likelihood of poor outcomes.
Those with blood cancers or lung cancer fared poorly in the first U.S. study of the new coronavirus n people with cancer.
Cancer-fighting T cells led to complete or partial tumor remission in at least 25% of lung cancer patients.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.